Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
About the journal
Open access to all articles
View the Editorial Board
Tracked/indexed by PubMed, PubMed Central, Medline, Thomson Reuters (ISI), CAS, EMBASE, Scopus, Current Contents and Google Scholar
Instructions for authors submitting a manuscript
Contact us
View the most accessed articles
RSS feed of the latest articles
Promote the journal Posters, leaflets, T-Shirts and more.
View answers to some Frequently Asked Questions





Editor-in-Chief: Delong Liu, New York Medical College

Journal of Hematology & Oncology provides a forum for top-quality research in the fields of hematology and oncology.

Submit your manuscript online.

Latest articles

Research    
RRM1 single nucleotide polymorphism -37C->A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy
Song Dong, Ai-Lin Guo, Zhi-Hong Chen, Zhen Wang, Xu-Chao Zhang, Ying Hang, Zhi Xie, Hong-Hong Yan, Hua Cheng, Yi-Long Wu
Journal of Hematology & Oncology 2010, 3:10 (13 March 2010)
[Abstract] [Provisional PDF] [PubMed] [Related articles]




Research    
Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
John J. Kavanagh, Charles F. Levenback, Pedro T. Ramirez, Judith L. Wolf, Carla L. Moore, Marsha R. Jones, Lisa Meng, Gail L Brown, Robert C. Bast Jr.
Journal of Hematology & Oncology 2010, 3:9 (11 March 2010)
[Abstract] [Provisional PDF] [PubMed] [Related articles]




Review    
From basic research to clinical development of MEK1/2 inhibitors for cancer therapy
Christophe Frémin, Sylvain Meloche
Journal of Hematology & Oncology 2010, 3:8 (11 February 2010)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]




Review    
Ovarian cancer immunotherapy: opportunities, progresses and challenges
Bei Liu, John Nash, Carolyn Runowicz, Helen Swede, Richard Stevens, Zihai Li
Journal of Hematology & Oncology 2010, 3:7 (10 February 2010)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]




Research    
CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment
Saloomeh Vahdat, Eric K Oermann, Sean P Collins, Xia Yu, Malak Abedalthagafi, Pedro DeBrito, Simeng Suy, Shadi Yousefi, Constanza J Gutierrez, Thomas Chang, Filip Banovac, Eric D Anderson, Giuseppe Esposito, Brian T Collins
Journal of Hematology & Oncology 2010, 3:6 (4 February 2010)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]




Review    
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
Jiahuai Tan, Shundong Cang, Yuehua Ma, Richard L Petrillo, Delong Liu
Journal of Hematology & Oncology 2010, 3:5 (4 February 2010)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]




Case report    
Complete response to FOLFOX4 therapy in a patient with advanced urothelial cancer: a case report
Yu Ri Seo, Se Hyung Kim, Hyun Jung Kim, Chan Kyu Kim, Seong Kyu Park, Eun Suk Koh, Dae Sik Hong
Journal of Hematology & Oncology 2010, 3:4 (20 January 2010)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]




register
Journal of Hematology & Oncology
BioMed Central
Current Controlled
Trials
PubMed
PubMed Central


 ISSN: 1756-8722

**

© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.